LPC

Lion Point Capital Portfolio holdings

AUM $19.3M
1-Year Est. Return 110.67%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+110.67%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$24.9M
AUM Growth
-$7.01M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
31
New
Increased
Reduced
Closed

Top Buys

1
+$1.38M
2
+$748K
3
+$362K
4
BNTC icon
Benitec Biopharma
BNTC
+$349K
5
ARQT icon
Arcutis Biotherapeutics
ARQT
+$346K

Top Sells

1
+$2.87M
2
+$1.98M
3
+$1.34M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$1.15M
5
KNSA icon
Kiniksa Pharmaceuticals
KNSA
+$1.05M

Sector Composition

1 Healthcare 94.86%
2 Technology 0.17%
3 Communication Services 0.07%
4 Consumer Discretionary 0%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$3.81M 15.29%
52,200
-18,135
2
$2.86M 11.47%
630,000
3
$2.55M 10.23%
370,000
-486,667
4
$2.51M 10.09%
1,654,154
-686,053
5
$1.77M 7.1%
+35,400
6
$1.53M 6.16%
61,400
-43,291
7
$1.25M 5%
49,000
8
$1.22M 4.9%
693,778
-1,421,049
9
$1.07M 4.31%
215,000
+45,000
10
$957K 3.84%
79,000
11
$889K 3.57%
46,200
-18,800
12
$839K 3.37%
64,000
-18,500
13
$820K 3.29%
78,913
+45,000
14
$606K 2.43%
57,750
+21,500
15
$602K 2.41%
32,000
16
$378K 1.52%
+7,700
17
$358K 1.44%
+39,000
18
$326K 1.31%
+35,100
19
$322K 1.29%
17,038
20
$153K 0.61%
39,589
-51,205
21
$43K 0.17%
100
22
$35.6K 0.14%
1,000
23
$16.7K 0.07%
100
24
– –
-7,423
25
– –
0
1
2